Frederik Persson

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Nish Chaturvedi, Akshay S. Desai, Marc A Pfeffer, 2012, The New England journal of medicine.

Improving the effectiveness of short‐term courses for multidisciplinary health care professionals

Sean McAleer, K. Kapur, F. Persson, 2015 .

Implementation of proteomic biomarkers: making it work

Raymond Vanholder, Fulvio Magni, David Maahs, 2012, European journal of clinical investigation.

Aliskiren combined with losartan in type 2 diabetes and nephropathy.

E. Lewis, H. Parving, J. Lewis, 2008, The New England journal of medicine.

YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.

Frederik Persson, Rikke Borg, 2018, Kidney international.